Morgans summary (as far as i can see they are the only broker covering it):
We value SLC at A$
2.74
(from A$2.81) per share using a Discounted Cash Flow with a
10% Weighted Average Cost of Capital.
SLC trades a
t a premium to
telecommunications peers and in our view, in order to justify this, SLC needs to
grow at
a faster
rate than peers. On our forecasts this is the case and therefore seems justified
,
however
SLC needs to successfully execute its sales strategy to deliver on this growth.
In our view
the key upside and downside risk for S
LC relates to the rate of sales. With
key assets now live, extensive and growing network coverage, additional sales staff
com
ing on board, and a strategic focus on
sales
, this
risk should now lie to the upside
.
- Forums
- ASX - By Stock
- Waiting for SLC to take off.
Morgans summary (as far as i can see they are the only broker...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.18 |
Change
0.040(1.87%) |
Mkt cap ! $897.5M |
Open | High | Low | Value | Volume |
$2.17 | $2.20 | $2.10 | $4.062M | 1.889M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14345 | $2.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.18 | 41155 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39999 | 1.720 |
1 | 13582 | 1.705 |
4 | 15717 | 1.700 |
1 | 5952 | 1.680 |
3 | 11300 | 1.670 |
Price($) | Vol. | No. |
---|---|---|
1.730 | 13582 | 1 |
1.735 | 32520 | 3 |
1.760 | 1530 | 1 |
1.765 | 8498 | 1 |
1.770 | 20000 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
SLC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online